Related Experiment Video
Updated: Feb 19, 2026

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
Published on: May 12, 2023
Management of acute bronchospasm in pediatric populations
1Capital Allergy and Respiratory Disease Center, Sacramento, California 95819, USA. bchipps@capitalallergy.com
Insights
Identifying children at risk for severe asthma attacks is crucial. Peak expiratory flow (PEF), FEV1, and SaO2 can predict exacerbation severity and hospitalization needs in pediatric asthma patients.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
Background:
- Asthma impacts over 6 million children in the US, necessitating early identification of severe exacerbation risks.
- Recognizing children prone to life-threatening bronchospasm is critical for timely intervention.
Purpose of the Study:
- To highlight the predictive value of key respiratory parameters in pediatric asthma exacerbations.
- To present clinical data on levalbuterol's safety and efficacy in children.
Main Methods:
- Review of clinical data focusing on peak expiratory flow (PEF), forced expiratory flow in 1 second (FEV1), and arterial oxygen saturation (SaO2).
- Analysis of these parameters as predictors for exacerbation severity, airflow obstruction, and hospitalization.
- Inclusion of safety and efficacy data for levalbuterol in pediatric patients.
Main Results:
- PEF, FEV1, and SaO2 are important indicators for predicting asthma exacerbation severity.
- These metrics help assess the degree of airflow obstruction and the likelihood of hospitalization.
- Levalbuterol demonstrates safety and efficacy in the pediatric asthma population.
Conclusions:
- Key respiratory measurements are vital for managing pediatric asthma exacerbations.
- Levalbuterol is a viable treatment option for children with asthma.
- Early identification of at-risk children can improve outcomes.
Abstract:
Asthma affects more than 6 million children in the United States. It is extremely important to recognize those children who are at risk of life-threatening bronchospasm episodes. This article outlines the importance of peak expiratory flow, (PEF), forced expiratory flow in 1 second (FEV1), and percent arterial oxygen saturation (SaO2) as predictors of the exacerbation severity, degree of airflow obstruction, and need for hospitalization. In addition, clinical data on the safety and efficacy of levalbuterol among pediatric patients are also presented.
Related Concept Videos
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma-IV: Nursing Management
First, in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
COPD: Management Using Bronchodilators and Corticosteroids

